Margaret von Mehren

Margaret von Mehren

UNVERIFIED PROFILE

Are you Margaret von Mehren?   Register this Author

Register author
Margaret von Mehren

Margaret von Mehren

Publications by authors named "Margaret von Mehren"

Are you Margaret von Mehren?   Register this Author

99Publications

2955Reads

34Profile Views

Intrigue: Phase III study of ripretinib versus sunitinib in advanced gastrointestinal stromal tumor after imatinib.

Future Oncol 2020 Jan 22;16(1):4251-4264. Epub 2019 Nov 22.

Portland VA Health Care System & OHSU Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0633DOI Listing
January 2020

Retroperitoneal Sarcomas: Does Laterality Matter?

J Surg Res 2019 12 3;244:34-41. Epub 2019 Jul 3.

Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2019.05.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815680PMC
December 2019

Soft tissue sarcoma of the extremity: Characterizing symptom duration and outcomes.

Surg Oncol 2019 Jun 21;29:190-195. Epub 2019 May 21.

Fox Chase Cancer Center, Department of Surgery, 333 Cottman Ave, Philadelphia, PA, 19111, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.suronc.2019.05.016DOI Listing
June 2019

Honing in on Subtypes to Guide More Individualized Treatment of Soft Tissue Sarcoma.

Oncology (Williston Park) 2019 06;33(6):212-4, 216

View Article

Download full-text PDF

Source
June 2019

Adjuvant Chemotherapy in Uterine Leiomyosarcoma: Trends and Factors Impacting Usage.

Sarcoma 2019 10;2019:3561501. Epub 2019 Feb 10.

Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/3561501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387708PMC
February 2019

Granular cell tumor experience at a comprehensive cancer center.

J Surg Res 2018 06 9;226:1-7. Epub 2018 Feb 9.

Department of Surgery, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2018.01.027DOI Listing
June 2018

Advances and Challenges on Management of Gastrointestinal Stromal Tumors.

Front Oncol 2018 7;8:135. Epub 2018 May 7.

Hematology, Oncology and Palliative Care, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2018.00135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949718PMC
May 2018

Gastrointestinal Stromal Tumors.

J Clin Oncol 2018 01 8;36(2):136-143. Epub 2017 Dec 8.

Margaret von Mehren, Fox Chase Cancer Center, Philadelphia, PA; and Heikki Joensuu, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.9705DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553810PMC
January 2018

Emerging drugs for the treatment of gastrointestinal stromal tumour.

Expert Opin Emerg Drugs 2017 12 18;22(4):317-329. Epub 2017 Dec 18.

b Director of Sarcoma Oncology, Associate Director for Clinical Research , Fox Chase Cancer Center , Philadelphia , PA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728214.2017.1411479DOI Listing
December 2017

Randomized Clinical Trials in Gastrointestinal Stromal Tumors.

Surg Oncol Clin N Am 2017 10 4;26(4):545-557. Epub 2017 Aug 4.

Department of Hematology/Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10553207173004
Publisher Site
http://dx.doi.org/10.1016/j.soc.2017.05.004DOI Listing
October 2017

Distress and Financial Distress in Adults With Cancer: An Age-Based Analysis.

J Natl Compr Canc Netw 2017 10;15(10):1224-1233

From Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2017.0161DOI Listing
October 2017

Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.

BMC Cancer 2017 Aug 2;17(1):512. Epub 2017 Aug 2.

Molecular Therapeutics Program, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111-2497, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-017-3499-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541693PMC
August 2017

Surgical Management of Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Pediatric and Wildtype GIST Clinic.

J Clin Oncol 2017 Feb 28;35(5):523-528. Epub 2016 Dec 28.

Christopher B. Weldon and Arin L. Madenci, Boston Children's Hospital; Christopher B. Weldon, Arin L. Madenci, Katherine A. Janeway, and Suzanne George, Harvard Medical School; Christopher B. Weldon, Katherine A. Janeway, and Suzanne George, Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Arin L. Madenci, Brigham and Women's Hospital, Boston, MA; Sosipatros A. Boikos, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA; Margaret von Mehren, Fox Chase Cancer Center, Philadelphia, PA; Alberto S. Pappo, St Jude Children's Research Hospital, Memphis, TN; Joshua D. Schiffman and Jennifer Wright, Huntsman Cancer Institute, Salt Lake City, UT; Jonathan C. Trent, Sylvester Comprehensive Cancer Center, Miami, FL; Karel Pacak and Constantine A. Stratakis, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Lee J. Helman, National Cancer Institute, Bethesda, MD; and Michael P. La Quaglia, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.6733DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455315PMC
February 2017

Management of Gastrointestinal Stromal Tumors.

Surg Clin North Am 2016 Oct;96(5):1059-75

Department of Hematology/Oncology, Fox Chase Cancer Center, C-218, 333 Cottman Avenue, Philadelphia, PA 19111, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00396109165201
Publisher Site
http://dx.doi.org/10.1016/j.suc.2016.05.011DOI Listing
October 2016

Efficacy of trabectedin for the treatment of liposarcoma.

Expert Opin Pharmacother 2016 Oct 15;17(14):1953-62. Epub 2016 Sep 15.

b Department of Hematology and Medical Oncology , Fox Chase Cancer Center , Philadelphia , PA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2016.1229304DOI Listing
October 2016

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

J Clin Oncol 2016 Mar 14;34(8):786-93. Epub 2015 Sep 14.

George D. Demetri, Dana-Farber Cancer Institute and Ludwig Center at Harvard, Boston, MA; Margaret von Mehren, Fox Chase Cancer Center; Arthur Staddon, University of Pennsylvania, Philadelphia; Hussein Tawbi, University of Pittsburgh Cancer Institute, Pittsburgh, PA; Robin L. Jones, Seattle Cancer Care Alliance, Seattle, WA; Martee L. Hensley, Memorial Sloan Kettering Cancer Center; Robert G. Maki, Mount Sinai Medical Center, New York, NY; Scott M. Schuetze, University of Michigan, Ann Arbor, MI; Mohammed Milhem, University of Iowa Hospitals and Clinics, Iowa City, IA; Anthony Elias, University of Colorado Cancer Center, Aurora, CO; Kristen Ganjoo, Stanford Hospital and Clinics, Stanford, CA; Brian A. Van Tine, Washington University in St Louis, St Louis, MO; Alexander Spira, Virginia Cancer Specialists, Fairfax, VA; Andrew Dean, St John of God Hospital-Bendat Cancer Centre, Subiaco, Western Australia, Australia; Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, and Trilok V. Parekh, Janssen Research & Development, Raritan, NJ; and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.62.4734
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.4734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070559PMC
March 2016

Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival.

J Natl Compr Canc Netw 2015 Nov;13(11):1366-74

From the Departments of Medical Oncology and Biostatistics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0165DOI Listing
November 2015

Phase I study of the safety and pharmacokinetics of trabectedin with docetaxel in patients with advanced malignancies.

Cancer Chemother Pharmacol 2015 May 20;75(5):1047-55. Epub 2015 Mar 20.

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2705-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978949PMC
May 2015

Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor.

Mol Cancer Ther 2014 Oct 13;13(10):2276-87. Epub 2014 Aug 13.

Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas. University of Kansas Cancer Center, Kansas City, Kansas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-14-0043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185217PMC
October 2014

GIST treatment options after tyrosine kinase inhibitors.

Curr Treat Options Oncol 2014 Sep;15(3):493-506

Department of Medical Oncology and Hematology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-014-0295-3DOI Listing
September 2014

Challenges in the treatment of angiosarcoma: a single institution experience.

Am J Surg 2014 Aug 15;208(2):254-9. Epub 2014 Apr 15.

Department of Surgical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2014.01.007DOI Listing
August 2014

Expression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective study.

World J Surg Oncol 2014 Jul 22;12:231. Epub 2014 Jul 22.

Hepato-Pancreato-Biliary Programs, Virginia Piper Cancer Institute, 800 E, 28th Street, Suite 602, Minneapolis, MN 55407, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1477-7819-12-231DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112617PMC
July 2014

Gastrointestinal stromal tumors, version 2.2014.

J Natl Compr Canc Netw 2014 Jun;12(6):853-62

From Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; The University of Texas MD Anderson Cancer Center; UC San Diego Moores Cancer Center; Moffitt Cancer Center; Memorial Sloan-Kettering Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; Dana-Farber/Brigham and Women's Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Roswell Park Cancer Institute; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; UCSF Helen Diller Family Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; City of Hope Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Duke Cancer Institute; University of Michigan Comprehensive Cancer Center; Vanderbilt-Ingram Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/6/853.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0080DOI Listing
June 2014

Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.

J Clin Oncol 2014 May 17;32(15):1563-70. Epub 2014 Mar 17.

Christopher L. Corless, Violetta Kolesnikova, Charles D. Blanke, Michael C. Heinrich, Oregon Health and Science University, Portland, OR; Karla V. Ballman, Mayo Clinic, Rochester, MN; Cristina R. Antonescu and Ronald P. DeMatteo, Memorial Sloan-Kettering Cancer Center; Robert G. Maki, Mt Sinai School of Medicine, New York, NY; Peter W.T. Pisters and Shreyaskumar Patel, University of Texas MD Anderson Cancer Center, Houston, TX; Martin E. Blackstein, Mount Sinai Hospital, Toronto, Ontario, Canada; George D. Demetri, Dana-Farber Cancer Institute, Boston, MA; Margaret von Mehren, Fox Chase Cancer Institute, Philadelphia, PA; Martin D. McCarter, University of Colorado School of Medicine, Aurora, CO; and Kouros Owzar, Duke University School of Medicine, Durham, NC.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.51.2046
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.51.2046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026579PMC
May 2014

Soft tissue sarcoma, version 2.2014.

J Natl Compr Canc Netw 2014 Apr;12(4):473-83

From 1Fox Chase Cancer Center; 2Huntsman Cancer Institute at the University of Utah; 3The University of Texas MD Anderson Cancer Center; 4UC San Diego Moores Cancer Center; 5Moffitt Cancer Center; 6Memorial Sloan-Kettering Cancer Center; 7Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 8Massachusetts General Hospital Cancer Center; 9Stanford Cancer Institute; 10Dana-Farber/Brigham and Women's Cancer Center; 11University of Alabama at Birmingham Comprehensive Cancer Center; 12Roswell Park Cancer Institute; 13The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 14Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 16UCSF Helen Diller Family Comprehensive Cancer Center; 17St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 18City of Hope Comprehensive Cancer Center; 19Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 20Duke Cancer Institute; 21University of Michigan Comprehensive Cancer Center; 22Vanderbilt-Ingram Cancer Center; 23Robert H. Lurie Comprehensive Cancer Center of Northwestern University; and 24National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/12/4/473.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2014.0053DOI Listing
April 2014

Differential expression of cysteine dioxygenase 1 in complex karyotype liposarcomas.

Biomark Cancer 2014 6;6:1-10. Epub 2014 Apr 6.

Department of Laboratory Oncology Research, Curtis and Elizabeth Anderson Cancer Institute, Memorial University Medical Center, Savannah, GA, USA. ; Department of Biomedical Sciences, Mercer University School of Medicine-Savannah Campus, Savannah, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/BIC.S14683DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3981480PMC
April 2014

Adolescent and young adult oncology, version 2.2014.

J Natl Compr Canc Netw 2014 Jan;12(1):21-32; quiz 32

From 1Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 2St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 3Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 4City of Hope Comprehensive Cancer Center; 5Vanderbilt-Ingram Cancer Center; 6The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 7Dana-Farber/Brigham and Women's Cancer Center; 8UCSF Helen Diller Family Comprehensive Cancer Center; 9Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 10Massachusetts General Hospital Cancer Center; 11Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 12Roswell Park Cancer Institute; 13Stanford Cancer Institute; 14Memorial Sloan-Kettering Cancer Center; 15The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 16Moffitt Cancer Center; 17Huntsman Cancer Institute at the University of Utah; 18The University of Texas MD Anderson Cancer Center; 19Fox Chase Cancer Center; 20Duke Cancer Institute; 21University of Alabama at Birmingham Comprehensive Cancer Center; 22University of Michigan Comprehensive Cancer Center; and 23National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0004DOI Listing
January 2014

Gastrointestinal stromal tumors: management of metastatic disease and emerging therapies.

Hematol Oncol Clin North Am 2013 Oct;27(5):905-20

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2013.07.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792495PMC
October 2013

Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor: ACOSOG Z9000 (Alliance) intergroup phase 2 trial.

Ann Surg 2013 Sep;258(3):422-9

*Memorial Sloan-Kettering Cancer Center, New York, NY †Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN ‡Oregon Health Sciences University, Portland, OR §Fox Chase Cancer Center, Philadelphia, PA ¶University of Colorado School of Medicine, Aurora, CO ‖Stanford University School of Medicine, Stanford CA **Mt Sinai School of Medicine, New York, NY ††University of Texas MD Anderson Cancer Center, Houston, TX ‡‡Dana Farber Cancer Institute, Boston, MA; and §§Alliance Statistics and Data Center, Duke University, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/SLA.0b013e3182a15eb7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041735PMC
September 2013

ZNF-mediated resistance to imatinib mesylate in gastrointestinal stromal tumor.

PLoS One 2013 25;8(1):e54477. Epub 2013 Jan 25.

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0054477PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556080PMC
July 2013

Head and neck sarcomas: a comprehensive cancer center experience.

Cancers (Basel) 2013 Jul 15;5(3):890-900. Epub 2013 Jul 15.

Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers5030890DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795370PMC
July 2013

Telomerase suppresses formation of ALT-associated single-stranded telomeric C-circles.

Mol Cancer Res 2013 Jun 15;11(6):557-67. Epub 2013 Mar 15.

Department of Laboratory Oncology Research, Curtis and Elizabeth Anderson Cancer Institute, Memorial University Medical Center, Savannah, Georgia 31404, USA.

View Article

Download full-text PDF

Source
http://mcr.aacrjournals.org/lookup/doi/10.1158/1541-7786.MCR
Publisher Site
http://dx.doi.org/10.1158/1541-7786.MCR-13-0013DOI Listing
June 2013

Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors.

Front Oncol 2013 17;3:117. Epub 2013 May 17.

Department of Medical Oncology, Fox Chase Cancer Center Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://journal.frontiersin.org/article/10.3389/fonc.2013.001
Publisher Site
http://dx.doi.org/10.3389/fonc.2013.00117DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656383PMC
June 2013

New drugs and combinations for the treatment of soft-tissue sarcoma: a review.

Cancer Manag Res 2012 23;4:397-411. Epub 2012 Nov 23.

Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.dovepress.com/new-drugs-and-combinations-for-the-
Publisher Site
http://dx.doi.org/10.2147/CMAR.S23257DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514064PMC
December 2012

Regorafenib induces rapid and reversible changes in plasma nitric oxide and endothelin-1.

Am J Hypertens 2012 Oct 12;25(10):1118-23. Epub 2012 Jul 12.

Division of Nephrology, Department of Medicine, Boston Children's Hospital, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajh.2012.97DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578478PMC
October 2012

Phase 1 study of MLN8054, a selective inhibitor of Aurora A kinase in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2011 Apr 7;67(4):945-54. Epub 2010 Jul 7.

UNC Lineberger Comprehensive Cancer Center, University of North Carolina, 170 Manning Drive, 3rd floor POB, CB 7305, Chapel Hill, NC 27599, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1377-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026871PMC
April 2011

Nilotinib: a novel, selective tyrosine kinase inhibitor.

Semin Oncol 2011 Apr;38 Suppl 1:S3-9

University Claude Bernard Lyon, Centre Léon Bérard, Department of Medicine, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2011.01.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004101PMC
April 2011

New therapies in soft tissue and bone sarcomas.

Clin Adv Hematol Oncol 2011 Apr;9(4):319-21

Sarcoma Program, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
April 2011

An unusual site of metastasis from gastrointestinal stromal tumor.

Rare Tumors 2010 Dec 31;2(4):e58. Epub 2010 Dec 31.

Division of Medical Oncology B, Regina Elena Cancer Institute, Rome, Italy;

View Article

Download full-text PDF

Source
http://www.pagepress.org/journals/index.php/rt/article/view/
Publisher Site
http://dx.doi.org/10.4081/rt.2010.e58DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019593PMC
December 2010

Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors.

Cancer 2010 Nov;116(22):5126-37

Leon Berard Center, Claude Bernard University, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167025PMC
November 2010

Doxorubicin resistance in a novel in vitro model of human pleomorphic liposarcoma associated with alternative lengthening of telomeres.

Mol Cancer Ther 2010 Mar 2;9(3):682-92. Epub 2010 Mar 2.

Department of Laboratory Oncology Research, Curtis and Elizabeth Anderson Cancer Institute, Memorial University Medical Center, Savannah, Georgia 31404, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-09-0705DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837520PMC
March 2010

Towards global consensus in the treatment of gastrointestinal stromal tumor.

Expert Rev Anticancer Ther 2010 Feb;10(2):221-32

Department of Hematology, Oncology and Palliative Medicine, HELIOS Klinikum Bad Saarow, Pieskower Strasse 33, D-15526 Bad Saarow, Germany.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/era.09.171
Publisher Site
http://dx.doi.org/10.1586/era.09.171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451074PMC
February 2010

Other targetable sarcomas.

Semin Oncol 2009 Aug;36(4):358-71

Sarcoma Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2009.06.008DOI Listing
August 2009

Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors.

J Clin Oncol 2009 Jul 18;27(19):3141-7. Epub 2009 May 18.

Ludwig Center, Dana-Farber/Harvard Cancer Center, Dana-Farber Cancer Institute, D1212, 44 Binney St, Boston MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.20.4818DOI Listing
July 2009

New therapeutic approaches for advanced gastrointestinal stromal tumors.

Hematol Oncol Clin North Am 2009 Feb;23(1):139-50, x

Department of Medical Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2008.12.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861350PMC
February 2009

Perioperative tyrosine kinase inhibitors for GIST: standard ... or an idea that needs further investigation?

Oncology (Williston Park) 2009 Jan;23(1):65-6

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861343PMC
January 2009

The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors.

Cell Cycle 2008 Oct 7;7(19):2949-55. Epub 2008 Oct 7.

Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626174PMC
http://dx.doi.org/10.4161/cc.7.19.6760DOI Listing
October 2008

Molecular mechanisms of action of imatinib mesylate in human ovarian cancer: a proteomic analysis.

Cancer Genomics Proteomics 2008 May-Aug;5(3-4):137-49

Division of Basic Science, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111-2497, USA.

View Article

Download full-text PDF

Source
October 2008